What Mycoril Vag Tab Treats: Main Uses and Benefits

Mycoril Vaginal Tablet is a focused therapeutic agent commonly used to help manage Vulvovaginal Candidiasis (VVC), widely known as a vaginal yeast infection or thrush. The primary purpose of the medication is to address the fungal overgrowth, which contributes to easing the overall symptom load. Vaginal clotrimazole is a recognized option for managing these infections when they occur.

Therapeutic Scope and Benefits

This medicine is applied in clinical settings that involve acute or disruptive symptom patterns driven by an active fungal pathogen, specifically Candida. It is relevant for easing symptoms related to inflammatory or irritative states, which include vaginal and vulval itching (pruritus), a painful burning sensation, local redness, soreness, and the thick, white, lumpy vaginal discharge. By addressing the mycotic issue, the tablet provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms.

The treatment is commonly used across conditions presenting with acute episodes and is applied in scenarios where additional management of discomfort is required. Managing these physical manifestations assists with maintaining functional stability.

---

Quick Fact: Relevant for Easing Symptoms Related to Irritation and Discharge

Regulatory References

1. NIH MedlinePlus overview

Eligibility Profile: Mycoril Vag Tab (Clotrimazole)

This information is based strictly on official regulatory labeling regarding population eligibility and exclusion for Clotrimazole vaginal tablets.

---

Absolute Contraindications and Restrictions

Category	Regulatory Statement
Contraindicated Populations	Individuals with known hypersensitivity to the active substance clotrimazole or to any other component (excipients) in the formulation.
Age Restriction	Not for use in children under 16 years of age. Medical advice is required for patients under 16 or over 60 years old.
Physiological States	Use is not recommended during menstruation due to the risk of reduced efficacy.

---

Conditional Use Requiring Medical Consultation

A healthcare provider must be consulted before using this medicine if a patient: has had more than two infections in the last six months (recurrent infection); has a history of a sexually transmitted disease; or presents with warning symptoms such as fever, chills, abdominal pain, or abnormal/blood-stained vaginal discharge.

Pregnancy and Lactation Status

Use during pregnancy requires medical supervision, and the applicator must not be used. A decision must be made regarding discontinuing breastfeeding while on treatment, as the substance may pass into breast milk.

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Mycoril Vag Tab (Clotrimazole) based on pharmacokinetic risks with certain medicines and physical constraints with specific products.

Documented Pharmacokinetic Interactions

Co-administration with certain oral immunosuppressant medicines can result in a significant pharmacokinetic interaction. The product label states that co-use with oral Tacrolimus and oral Sirolimus might lead to increased plasma levels of these immunosuppressants.

Interacting Medicine	Official Outcome / Requirement
Oral Tacrolimus	Increased plasma levels, requiring close monitoring.
Oral Sirolimus	Increased plasma levels, requiring close monitoring.

Documented Product and Administration Restrictions

There are documented restrictions involving physical interactions and administration timing. The product may cause physical damage to medical products made of latex (such as condoms, diaphragms, and cervical caps), thereby reducing their effectiveness. For this reason, official labeling requires that alternative non-latex precautions be used for at least five days following treatment.

Furthermore, the regulatory text restricts the simultaneous use of tampons, intravaginal douches, spermicides, or other vaginal products, as these substances may interfere with the intended action of the medicine.

How Mycoril Vag Tab Works

Blocking the Fungal Cell's Structural Production

This medication acts by inhibiting a fungal enzyme, P450 14alpha-demethylase, which is required to synthesize ergosterol, the primary structural component of the fungal cell membrane. This interference with the ergosterol biosynthesis pathway prevents the organism from assembling a stable and functional cell membrane structure.

---

Causing Lethal Membrane Instability

The failure to produce a functional cell membrane causes it to become porous and structurally compromised, leading to the accumulation of toxic intermediary substances and the leakage of critical intracellular components. This localized, peripheral action on the fungal cell's integrity culminates in the organism's irreversible cell death, which results in the inhibition of fungal cell proliferation.

The use of Mycoril Vag Tab (Clotrimazole Vaginal Tablet) is based on specific administration protocols. The approved route of administration is vaginal (topical), ensuring the active ingredient is delivered directly to the required site. Standardized dosing regimens are established for this medication. These options include short-course administration using either the 500 mg strength for a single-day treatment, or 100 mg strength used in either a 3-day or 6-day course. Administration is scheduled once daily and must be performed at bedtime, with the tablet inserted as high as possible into the vagina, typically with an applicator.

Dosing Regimen	Tablet Strength & Frequency	Course Duration
Single-Dose	One 500 mg tablet	1 day
Multi-Day	One or two 100 mg tablets, once daily	3 to 6 days

Special procedural conditions govern the treatment course. The full duration must be completed, and generally should not be used during menstruation. Contraceptive and concurrent product restrictions are also mandated; for instance, concurrent use of tampons, douches, or spermicides is strictly avoided. Furthermore, the medicine may reduce the efficacy of latex (rubber) contraceptives, requiring the use of alternative precautions for at least five days following the treatment course. Population-specific guidance confirms that use during pregnancy requires the tablet to be inserted without using an applicator. No specific dosage adjustment is required for older adults. A second treatment course may be initiated if symptoms persist or return after seven days.

Research Evidence / Overview of Studies for Mycoril Vag Tab

---

Evidence for Use in Uncomplicated Vaginal Yeast Infections (VVC)

The research base for Clotrimazole vaginal tablets includes Randomized Controlled Trials (RCTs) and Systematic Reviews exploring simple or first-time vaginal yeast infections. These studies typically involved adult women with a confirmed infection, predominantly Candida albicans. Researchers examined two main endpoints: measured fungal status (the absence of the fungus) and changes in clinical status (the measured changes in symptom scores for conditions like itching and irritation).

Studies report patterns related to how symptoms changed in the observed populations and reported measured patterns related to fungal negativity in the short term. While evidence related to short-term fungal status is substantial, the results apply mainly to the specific populations studied within the trial settings.

---

Evidence for Use in Severe or Recurrent Infections

Research has also explored the active ingredient, Clotrimazole, in studies examining conditions characterized by more complex manifestations, specifically in severe VVC (high symptom severity) and recurrent VVC (frequent returns). Studies examined outcomes such as the degree of change measured in initial symptom scores and the time to subsequent relapse.

Findings described patterns related to measured short-term symptom changes. The overall evidence quality for these complicated cases varies across studies, and some meta-analyses described mixed findings related to long-term clinical status when different azole compounds were observed.

---

Research Gaps and What Remains Uncertain

The evidence landscape, while substantial in volume for acute uncomplicated VVC, has several areas where certainty remains low or data are still emerging. Long-term outcomes related to preventing future episodes are not fully established for the majority of patients after short treatment courses. Additionally, comparative evidence is lacking for certain non-standard groups, such as patients who have co-existing health conditions or those whose infections are caused by less common fungal species.

Key Studies & References

1. Treatment of vulvovaginal candidiasis in pregnancy: a review of available agents

Common questions about Mycoril Vag Tab (FAQ)

Q: What is Mycoril Vag Tab used for?

A: Mycoril Vag Tab is an antifungal medicine primarily used to treat vaginal yeast infections (vulvovaginal candidiasis) caused by the fungus Candida.

---

Q: How do I use Mycoril Vag Tab?

A: It is typically inserted into the vagina, usually once daily, often at bedtime, for the full course of treatment as prescribed by your healthcare provider. Wash your hands before and after using the applicator or tablet. Follow your provider's specific instructions, even if your symptoms improve sooner.

---

Q: What should I do if I miss a dose?

A: If you miss a dose, use it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not use two doses at the same time to make up for a missed dose. Consult your healthcare provider if you have concerns about a missed dose.

---

Q: What are common side effects of Mycoril Vag Tab?

A: Common side effects may include mild vaginal burning, itching, or irritation at the application site. Less common effects might include abdominal pain or cramps. If these effects are severe or do not go away, contact your healthcare provider.

---

Q: Can I use Mycoril Vag Tab during my menstrual period?

A: Generally, it is best to avoid using Mycoril Vag Tab during menstruation as the treatment might be less effective. It is important to continue treatment for the full prescribed duration, even if your period starts. Discuss the best approach with your healthcare provider, who may recommend timing the start of treatment or other specific instructions.

---

Q: Can Mycoril Vag Tab affect birth control methods?

A: Mycoril Vag Tab, particularly the inactive ingredients or oily nature of some formulations, can weaken latex condoms and diaphragms. This can make these forms of birth control less effective in preventing pregnancy or sexually transmitted infections. You should use alternative, non-latex barrier methods or abstain from vaginal intercourse during treatment and for a short time after.

---

Q: How should I store Mycoril Vag Tab?

A: Store the tablets at room temperature away from heat, moisture, and direct light. Do not store it in the bathroom. Keep the medicine out of the reach of children.

How to Store and Dispose of Mycoril Vag Tab

Official regulatory information requires specific conditions to maintain the stability and safety of this product.

Storage Requirements

Condition	Requirement
Temperature	Store at a controlled room temperature, typically below 25 C or 30 C and do not freeze.
Protection	Keep the tablets in the original blister packaging and carton to protect them from light and moisture.
Stability	Do not use the medicine after the expiration date printed on the package.
Child Safety	Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired Mycoril Vaginal Tablets and the used applicator must be disposed of in accordance with local government regulations for pharmaceutical waste. To ensure environmental safety, the medicine must not be thrown in household trash or disposed of via wastewater (such as flushing down the toilet).